Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Bilastine by Faes Farma for Allergic Conjunctivitis: Likelihood of Approval
Bilastine is under clinical development by Faes Farma and currently in Phase III for Allergic Conjunctivitis. According to GlobalData, Phase...